SEC Form 4 · accession 0000914760-16-000324
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory M. Bortz
Director
Period of report
Jan 6, 2016
Accepted (ET)
Jan 21, 2016 · 10:12 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (to acquire common stock)F1 | $4.66 | Jan 6, 2016 | A | 63,291 | A | Jan 7, 2017 | Jan 5, 2021 | Common Stock | 63,291 | 257,455 | D |
Explanation of responses
- F1The Reporting Person was granted 63,291 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 7, 2017.